FDA approves first generic of Mylan’s EpiPen
The US Food and Drug Administration (FDA) has approved the first generic version of the EpiPen and EpiPen Jr (epinephrine)...
Trending:
-
![Realm Therapeutics]()
Realm Therapeutics unveils phase II failure of PR022 for severe eczema
-
![HIV-1]()
Janssen and ViiV report positive results for two drug regimen for HIV-1
-
![nusinersen]()
NICE does not recommend NHS use of Biogen’s nusinersen for SMA
-
![remifentanil]()
Study shows remifentanil better at relieving pain in labour than current standard care
-
![]()
Big soil: Genentech and Lodo launch $1bn project to develop new drugs from earth
-
![PhRMA survey]()
PhRMA survey shows US biopharma exceeded R&D spending record in 2017
Expert commentary & analysis from GlobalData
ILC Dover flexible isolators: A cost-effective way to maximise containment
So you want to break into the Chinese vaccine market?
After Zavante deal, Nabriva is poised to launch two first-in-class antibiotics
Revlimid demonstrates positive phase III results in Indolent NHL
Most Read
Company releases
Upcoming Pharmaceutical Courses from NSF
NSF has announced a wide range of upcoming courses related to the pharmaceutical industry. Make sure you remember to take...
MUNIT to Participate at Pharmaceutical ChemOutsourcing, New Jersey
New Strategies to Promote Compliance and Inspection Readiness
Join trial management file (TMF) experts and industry professionals for a series of informative sessions and panel discussions on the...
NextGenAAV
Gerresheimer at Medtec China
Gerresheimer develops and produces innovative drug delivery systems and medical and diagnostic products for prestigious...
Company whitepapers
Innovations in API Solubility and Bioavailability
Laboratoria SmeetsGetting to the Bottom of Data Integrity: Four to Explore
NSF International, Pharma BiotechFast and Reliable Quantification of Data
Malvern PanalyticalGT X.ONE – Excellence in Granulation Technology
ACG Associated CapsulesPatch Pump Applications
Weibel CDSNinconex Medical Brochure
Niconex MedicalPharmaceutical Challenges Aided by Laboratory Powder X-ray Diffraction
Malvern PanalyticalCompany A-Z
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.
Projects
Boehringer Ingelheim’s Integrated Asian Veterinary R&D Centre, Shanghai
Germany-based pharmaceutical company Boehringer Ingelheim’s veterinary research and development (R&D) centre is located within its R&D plant site in Shanghai, China.
Amgen’s New Bio-manufacturing Plant, Rhode Island, US
Chugai Pharmaceutical’s New Synthetic Research Facility, Tokyo
Eisai Centre for Genetics Guided Dementia Discovery, Massachusetts, US
Minakem’s High-Containment Production Facility, Louvain-la-Neuve, Belgium
Clinical Trials
Fasinumab Phase III osteoarthritis trial meets endpoints
Teva Pharmaceutical and Regeneron Pharmaceuticals have reported positive top-line data from a phase III clinical trial of fasinumab to treat chronic pain in patients with...
Realm Therapeutics unveils phase II failure of PR022 for severe eczema
Janssen and ViiV report positive results for two drug regimen for HIV-1
US FDA accepts the NDA for Motif Bio’s iclaprim for ABSSSI treatment
Seattle Children’s launches new CAR T-cell immunotherapy trial
Drug Development
Fasinumab Phase III osteoarthritis trial meets endpoints
Teva Pharmaceutical and Regeneron Pharmaceuticals have reported positive top-line data from a phase III clinical trial of fasinumab to treat chronic pain in patients with...
BioNTech signs $425m flu vaccine deal with Pfizer
Realm Therapeutics unveils phase II failure of PR022 for severe eczema
Janssen and ViiV report positive results for two drug regimen for HIV-1
RXi and Karolinska Institutet target solid tumour therapy
Market Data
Deals and M&As this week: Aralez Pharmaceuticals, Perrigo, Takeda
Aralez Pharmaceuticals has entered two purchase agreements to sell its main operating businesses, Vimovo and Toprol-XL, for $250m.
Study shows remifentanil better at relieving pain in labour than current standard care
Deals this week: Pharmaxis, Almirall, Cipla Quality Chemical Industries
Spark Therapeutics Q2 financial results: income growth helped by US launch of Luxturna
Mylan Q2 financial results: revenue decline led by falling sales in North America
Technology
PhRMA survey shows US biopharma exceeded R&D spending record in 2017
Spending by members of the Pharmaceutical Research and Manufacturers of America (PhRMA) on research and development (R&D) set a new record by totalling $71.4bn in...
AI technology to help design personalised combination therapy
UNC develops artificial intelligence system to design new drugs
New UK Health Secretary lays out major priorities for the NHS
Roche and PureTech to develop oral antisense oligonucleotides